Table 2

Relation between disease recurrence within 12 months in superficial (i.e., pTa, pT1) bladder cancer patients and the FGFR3 mutation status (n = 57)

FGFR3 mutation analysis
Wild typeMutationPa
12 months follow-up
Recurrence-free9270.004
Recurrence147
Total2334
  • a P was determined by two-sided Fisher’s exact test calculated for a 2 × 2 table.